RJK002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RJK002, covering 2025-08-28 to 2025-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis [Phase 1]